...
首页> 外文期刊>American Journal of Translational Research >miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition
【24h】

miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition

机译:miR-132通过阻止USP9X诱导的上皮-间质转化抑制肺癌细胞的迁移和侵袭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

miR-132, a microRNA, has been reported to be down-regulated in several human cancers and is related with tumor progression; however, its function in non-small cell lung cancer (NSCLC) progression remains unclear. This study aimed to investigate the putative role of miR-132 in the metastasis of NSCLC. We determined the function of miR-132 in the migration and invasion of a NSCLC cell line in vitro using a miR-132 inhibitor and mimic. Our results showed overexpression of miR-132 significantly inhibited the migration and invasion of NSCLC cells in vitro. We then identified USP9X as a potential target of miR-132, and demonstrated miR-132 could regulate the expression of USP9X at both the mRNA and protein level. miR-132 could directly bind to the 3’ untranslated region (3’-UTR) of USP9X. Inhibition of USP9X by its inhibitor WP1130 reduced the migration and invasion of NSCLC cells. Furthermore, USP9X inhibition also reversed the increased migration and invasion mediated by miR-132 inhibition. We found USP9X inhibition up-regulated expression of the epithelial-mesenchymal transition (EMT) marker E-cadherin, but down-regulated vimentin expression. A similar effect was seen with miR-132 overexpression, while the opposite effect occurred with miR-132 knockdown. USP9X inhibition reversed the miR-132 inhibitor-induced vimentin up-regulation and E-cadherin down-regulation. Taken together, these results indicate miR-132 prohibits the migration and invasion of NSCLC cells via targeting USP9X-induced EMT. Our data provides further evidence for the critical role of miR-132 and USP9X in regulating cell invasion and migration of NSCLC.
机译:据报道,miR-132是一种microRNA,在几种人类癌症中均被下调,并且与肿瘤进展有关;然而,其在非小细胞肺癌(NSCLC)进展中的功能仍不清楚。本研究旨在探讨miR-132在NSCLC转移中的假定作用。我们使用miR-132抑制剂和模拟物确定了miR-132在NSCLC细胞系迁移和侵袭中的功能。我们的结果表明,miR-132的过表达显着抑制了NSCLC细胞的迁移和侵袭。然后,我们确定USP9X是miR-132的潜在靶标,并证明miR-132可以在mRNA和蛋白质水平上调节USP9X的表达。 miR-132可以直接绑定到USP9X的3'非翻译区(3'-UTR)。 USP9X的抑制剂WP1130抑制了NSCLC细胞的迁移和侵袭。此外,USP9X抑制作用还逆转了miR-132抑制作用介导的迁移和侵袭增加。我们发现USP9X抑制上皮-间质转化(EMT)标记E-钙黏着蛋白的表达上调,但波形蛋白的表达下调。 miR-132过表达可观察到类似效果,而miR-132敲低则可产生相反效果。 USP9X抑制逆转了miR-132抑制剂诱导的波形蛋白上调和E-钙粘蛋白下调。综上所述,这些结果表明miR-132通过靶向USP9X诱导的EMT阻止了NSCLC细胞的迁移和侵袭。我们的数据为miR-132和USP9X在调节NSCLC细胞侵袭和迁移中的关键作用提供了进一步的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号